2025. Initial Clinical Experience with Established and Novel Radiopharmaceuticals for Radionuclide Therapy. Voprosy onkologii. 71, 5 (Nov. 2025), OF-2250. DOI:https://doi.org/10.37469/0507-3758-2025-71-5-OF-2250.